 |
 Video: What is a Stock Split?
|
|
|
| Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Co.'s product is a drug-device combination consisting of molgramostim nebulizer solution (drug component) and a vibrating mesh nebulizer (device component). Molgramostim nebulizer solution is vialed as a sterile formulation containing molgramostim solution. Molgramostim nebulizer solution is administered once daily by inhalation via a high efficiency nebulizer, the eFlow® Nebulizer System. The eFlow® Nebulizer System is a reusable electronic inhalation system for administration of molgramostim nebulizer solution. The eFlow® consists of a controller unit, a nebulizer handset, and a connection cord. According to our Savara stock split history records, Savara has had 0 splits. | |
|
Savara (SVRA) has 0 splits in our Savara stock split history database.
Looking at the Savara stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Savara shares, starting with a $10,000 purchase of SVRA, presented on a split-history-adjusted basis factoring in the complete Savara stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
05/02/2017 |
|
| End date: |
05/03/2024 |
|
| Start price/share: |
$7.84 |
|
| End price/share: |
$4.71 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-39.99% |
|
| Average Annual Total Return: |
-7.03% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$5,999.84 |
|
| Years: |
7.01 |
|
|
|
|
|
